JW Group Vows To Foster C&C Research Labs As Global Biotech Firm
South Korea’s JW Pharmaceutical Corp. and Japan’s Chugai Pharmaceutical Co. will foster their joint biotech venture C&C Research Labs with a focus on innovative oncology drugs, JW Group chairman Lee Kyung-ha told reporters.
During a press conference held in downtown Seoul on Wednesday, Lee said "C&C Research Labs’ Core Technology Platform is designed to develop innovative novel drugs. We want to build it like Gilead Sciences and Genentech which run their business on in-house developments or out-licensing collaborations.”
During a press conference held in downtown Seoul on Wednesday, Lee said "C&C Research Labs’ Core Technology Platform is designed to develop innovative novel drugs. We want to build it like Gilead Sciences and Genentech which run their business on in-house developments or out-licensing collaborations.”